Good laboratory practice and current good manufacturing practice requirements in the development of cancer nanomedicines

Abstract The product authorization from the market can be achieved by following good manufacturing practice (GMP) regulations. It assures the quality of the product by monitoring the materials used in the manufacturing of the product. Reliable products are produced and launched in the market. Quality management of nonclinical safety studies comes under the good laboratory practice (GLP) regulation. The purpose of the regulation is to encourage scientists to arrange and perform their studies in a way that assists the quality and validity of the test data. Novel drug deliveries like nanomedicine have been approved for clinical use if developed as per the GLP and current good manufacturing practice (cGMP) guidelines.